Bombay High Court Neutralizes FDA Restrictions on ACILOC Drug Stocks, Orders Fresh Proceedings

The Bombay High Court has ordered the Food and Drug Administration (FDA) to recall restrictions on ACILOC drug stocks, effectively neutralizing previous notices. The court directed the FDA to initiate fresh proceedings in accordance with the law, following a challenge to orders that imposed restrictions on the disposal, distribution, and sale of ACILOC drug stocks.